StemGen, Inc. announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced sales was USD 1,750 compared to USD 10,000 a year ago. Operating loss was USD 20,843 compared to USD 61,018 a year ago. Net loss was USD 61,767 compared to USD 61,018 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 1,750 compared to USD 10,000 a year ago. Operating loss was USD 34,024 compared to USD 110,604 a year ago. Net loss was USD 115,879 compared to USD 110,604 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.